World News: 14:12 GMT Tuesday 14th January 2020. [physIQ via Businesswire via SPi World News]
, a pioneer in healthcare analytics, has made the Observer’s list of that will be in attendance at the 38th annual JP Morgan Healthcare Conference in San Francisco, CA. The publication included PhysIQ based on its mission to deliver on the promise of scalable personalized medicine by applying artificial intelligence to biosensor data and transforming it into personalized patient insights.
This press release features multimedia. View the full release here:
PhysIQ Named One of 2020’s Hottest Flyover Tech Companies in Digital Health (Graphic: Business Wire)
Thecontinues to highlight that the healthcare technology industry is becoming increasingly excited about startups coming out of “Flyover Country,” i.e., the land between our two coasts. Headquartered in Chicago, IL, physIQ continues to revolutionize clinical research and healthcare delivery. The company has developed an AI-based solution that continuously streams real world physiological data to the cloud, where highly sophisticated, FDA cleared analytics analyzes the patient data and evaluates changes to their physiology.
“Twenty years ago, we developed the foundation of this technology to monitor the health of mission-critical industrial assets, ranging from airplane engines to nuclear power plants. Today we are applying our technology to the most important machine to date – the human machine. Partnering with some of the world’s leading pharmaceutical companies and health care systems we are excited to play a role in changing how healthcare is developed and delivered,” says physIQ’s CEO,. “We appreciate this recognition by the Observer, as we continue to enable proactive and personalized care delivery with world-class technology with one goal in mind, improving patient outcomes.”
Coming off a monumental 2019, physIQ is geared up for an even better 2020. With partnerships already formed with some of the largest healthcare and life science companies in the world, to growing their portfolio of FDA-cleared analytics by receiving their third 510(k) clearance, physIQ is poised and ready to provide clinicians with the tools they need to proactively engage at-risk patient populations, as well as provide pharmaceutical companies with powerful data-driven support to demonstrate the efficacy of their products.
PhysIQ is delivering a true end-to-end solution for real-world continuous physiological data capture and analysis in a way that will transform healthcare as we know it.
PhysIQ is a company dedicated to enabling proactive care delivery models through its highly scalable cloud-based platform for personalized physiology analytics. Our FDA 510(k)-cleared data analytics platform is designed to process multiple vital signs from wearable sensors to create a personalized dynamic baseline for each individual. By mapping vital sign relationships this way, physIQ’s analytics detect subtle deviations that may be a precursor to disease exacerbation or change in health. With applications in both healthcare and clinical trial support, physIQ is transforming continuous physiological data into insight for providers, health systems, payers and pharmaceutical and medical device companies.
For more information, please visit. Follow us on and .
Business Wire: 14:12 GMT Tuesday 14th January 2020
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.